Polyclonal Rabbit anti-Human SLC5A11 / SMIT2 Antibody (WB)
Catalog Number: LS-C748223
2 sizes / from $281.00
Antibody: Rabbit Polyclonal
Applications: Immunohistochemistry (general), Western Blot
Reactivity: Human, Mouse, Rat
Format: Liquid
Immunohistochemistry of paraffin-embedded Human colon cancer using TBX2 Polyclonal Antibody at dilution of 1:32.
Polyclonal Rabbit anti-Human TBX2 Antibody (IHC)
Primary AntibodyLSBio Guarantee
| Antibody: | Rabbit Polyclonal |
| Applications: | Enzyme-Linked Immunosorbent Assay, Immunohistochemistry (general) |
| Reactivity: | Human, Mouse |
| Format: | Liquid |
$260.00each
Catalog Number: LS-C402301-20
Catalog Number: LS-C402301
For bulk orders or custom formulations:
Request a QuoteOverview
- Description
- TBX2 antibody LS-C402301 is an unconjugated rabbit polyclonal antibody to TBX2 from human. It is reactive with human and mouse. Validated for ELISA and IHC. Cited in 2 publications.
- Application
- ELISA, IHC
- Reactivity
- Hu, Ms
- Intended Use
- Research Use Only
- Guarantees
- This antibody carries the LSBio 100% Guarantee. ✓
- Category
- Antibodies > Primary Antibodies > Polyclonal Antibodies
- Alternative Names
- T-box 2 | T-box protein 2 | TBX2
- Recommended Dilution: IHC
- 1:32
- UniProt Number
- Q13207
- NCBI GenBank
- NM_005994 | NP_005985.3
- SwissProt
- Q13207
Target
- Target
- Human TBX2
- Antigen Species
- Human
- Epitope
- Human TBX2
- Gene Name
- TBX2
Antibody
- Host Species
- Rabbit
- Clonality
- Polyclonal
- Isotype
- IgG
Immunogen
- Immunogen
- Synthetic peptide from human TBX2.
- Immunogen Type
- Synthetic Peptide (Linear)
Format
- Conjugate/Label
- Unconjugated
- Format
- Liquid
- Formulation
- PBS, pH 7.4, 0.05% Sodium Azide, 50% Glycerol
- Concentration
- 0.5 mg/mL
- Volume
- 20 Microliter
- Preservative
- Yes
- Purification Method
- Affinity Purified
Storage & Handling
- Storage Conditions
- Store at -20°C. Avoid freeze-thaw cycles.
- Recommended Storage Buffer
- PBS
TBX2 expression is associated with platinum-sensitivity of ovarian serous carcinoma. Tasaka R, Fukuda T, Shimomura M, Inoue Y, Wada T, Kawanishi M, Yasui T, Sumi T. Oncology letters. 2018 March;15:3085-3090.
PubMed: 29435041 · PMC: PMC5778828
T-box 2 expression is a useful indicator of the response to neoadjuvant chemotherapy for patients with locally advanced uterine cervical squamous cell carcinoma. Yuta Inoue, Takeshi Fukuda, Shigenori Nanno, Yuichiro Awazu, Masahiro Shimomura, Hiroaki Matsubara, Makoto Yamauchi, Tomoyo Yasui, Toshiyuki Sumi. Oncology letters. 2021 Nov;;22:755.
PubMed: 34539859 · PMC: PMC8436333
